BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 4352150)

  • 1. Anaesthesia for open-heart surgery in haemodialysis-dependent patients: a report of two cases.
    Allen FB; Kane PB
    Can Anaesth Soc J; 1982 Mar; 29(2):158-62. PubMed ID: 7066740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.
    Bevan DR; D'Souza JD; Rouse JM; Caldwell J; Smith RL
    Eur J Clin Pharmacol; 1981; 20(4):293-8. PubMed ID: 6118278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancuronium and renal perfusion: a comparison of neuromuscular blocking agents.
    Leighton KM; Koth B; Bruce C
    Can Anaesth Soc J; 1974 Mar; 21(2):131-8. PubMed ID: 4274253
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants.
    Booij LH
    Pharm Weekbl Sci; 1987 Apr; 9(2):56-60. PubMed ID: 2954027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of muscle relaxants.
    Wingard LB; Cook DR
    Clin Pharmacokinet; 1977; 2(5):330-43. PubMed ID: 913003
    [No Abstract]   [Full Text] [Related]  

  • 6. Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
    Miller RD; Roderick L
    Br J Pharmacol; 1977 Aug; 60(4):555-8. PubMed ID: 907868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1977 Aug; 12(1):23-9. PubMed ID: 332502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancuronium bromide: a review of its pharmacological properties and clinical application.
    Speight TM; Avery GS
    Drugs; 1972; 4(3):163-226. PubMed ID: 4264763
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man.
    Miller RD; Stevens WC; Way WL
    Anesth Analg; 1973; 52(4):661-6. PubMed ID: 4352150
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical study of pancuronium as muscle relaxant in anesthesia.
    Park WY; Macnamara TE
    Anesth Analg; 1973; 52(4):502-7. PubMed ID: 4123904
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pancuronium bromide (Pavulon) in urologic surgery].
    Lübke P; Bihler K
    Z Prakt Anasth; 1971 Jul; 6(3):161-8. PubMed ID: 4111517
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.